Document Detail

Hemofiltration as a treatment for end-stage renal disease.
MedLine Citation:
PMID:  19379415     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Patients treated for end-stage renal disease (ESRD) have a poorer quality of life and a higher mortality rate than patients in the general population. In addition, the cost to provide ESRD care is tremendous. Daily hemodialysis programs have been associated with improvements in the patient's quality of life, anemia management, blood pressure, nutrition, and left ventricular hypertrophy. In addition, especially when treated at home, cost savings are possible. Daily hemofiltration may offer additional benefits with enhanced middle-molecule clearance, improved cardiovascular stability, and perhaps a further reduction in cost. Finally, ease of use of the NxStage System One may encourage patients to undergo their treatment at home.
Deborah L Zimmerman
Related Documents :
20392575 - Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an ...
21729225 - Subarachnoid hemorrhage in elderly: advantages of the endovascular treatment.
8825135 - Use of hospital services by breast cancer patients by stage of the disease: implication...
17081165 - Cost-utility analysis of different peg-interferon alpha-2b plus ribavirin treatment str...
11247865 - Employment, work disability, and work days lost in patients with ankylosing spondylitis...
9855165 - The role of weight loss and acetazolamide in the treatment of idiopathic intracranial h...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hemodialysis international. International Symposium on Home Hemodialysis     Volume:  8     ISSN:  1492-7535     ISO Abbreviation:  Hemodial Int     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2009-04-21     Completed Date:  2009-12-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101093910     Medline TA:  Hemodial Int     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  183-7     Citation Subset:  -    
Department of Medicine, Division of Nephrology, Kidney Research Center, University of Ottawa, Ottawa, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ultrapure dialysis fluid: Improving conventional and daily dialysis.
Next Document:  Urea standard Kt/V for assessing dialysis treatment adequacy.